Document is current
Any future updates will be listed below
-
Authors
Pi, Zhilong
Wu, You
Wu, Jingyi
Zhang, Tao
Li, Pingyue
Wang, Renkai https://orcid.org/0000-0002-3942-8739
-
Funding
Funding for this research was provided by:
Guangzhou Municipal Science and Technology Project (2024A03J0690)
Guangzhou Science, Technology and Innovation Commission (2023A03J0693)
Guangzhou Municipal Science and Technology Project (2024A03J0634)
Natural Science Foundation of Guangdong Province (2022A1515010307, 2024A1515012050)
- License Information
-
More Information
Article History
Received: 1 January 2025
Accepted: 10 June 2025
First Online: 16 July 2025
Declarations
:
: This study was approved by the Medical Research Ethics Board of the General Hospital of Southern Theater Command of PLA (title: exosomal CRELD2 promotes angiogenesis and osteogenesis via the PERK-ATF4-CRELD2 pathway. Approval number: No. 2023110101. Date of approval: 20231101). All methods were carried out in accordance with relevant guidelines and regulations. HUVECs were purchased from a commercial vendor (Procell, China), which information and ethics can be found on its official website (Information and ethics can be found on its official website ().
: Not applicable.
: The authors declare that they have no conflicts of interest. The authors declare that they have not use AI-generated work in this manuscript.
